U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9054190541Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)RecruitingNo Results AvailableLiver Cirrhosis|Chronic Hepatitis BDrug: telbivudinehttps://ClinicalTrials.gov/show/NCT01380951
9054290542Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE)RecruitingNo Results AvailableChronic HepatitisDrug: Peginterferon alpha-2a + Ribavirinhttps://ClinicalTrials.gov/show/NCT01380938
9054390543The Jewels in Our Genes Study - an African American Family Study of Breast CancerCompletedNo Results AvailableBreast Cancerhttps://ClinicalTrials.gov/show/NCT01380925
9054490544Can Methylprednisoloneacetate Prevent Seroma After Mastectomy for Primary Breast CancerRecruitingNo Results AvailableBreast CancerDrug: methylprednisoloneacetatehttps://ClinicalTrials.gov/show/NCT01380912
9054590545Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.Active, not recruitingNo Results AvailableParkinson Disease|Parkinsonian DisordersProcedure: Biopsy of skinhttps://ClinicalTrials.gov/show/NCT01380899
9054690546Growth and Tolerance of Young Infants Fed Infant FormulasCompletedNo Results AvailableInfant NewbornOther: experimental infant formula with alternate protein source|Other: Infant formula powderhttps://ClinicalTrials.gov/show/NCT01380886
9054790547A Pharmacodynamic Study of SLM0807, HKB0701 and CJ30001 in Healthy SubjectCompletedNo Results AvailableDiabetes MellitusDrug: Period I : HKB0701, Period II : HKB0701 and SLM0807, Period III : CJ30001|Drug: Period I : HKB0701 and SLM0807, Period II : CJ30001, Period III : HKB0701|Drug: Period I : CJ30001, Period II : HKB0701, Period III : HKB0701 and SLM0807https://ClinicalTrials.gov/show/NCT01380873
9054890548Primary Prevention of Peristomial Hernias Via Parietal ProsthesesRecruitingNo Results AvailableParastomal HerniaProcedure: Colostomy with mesh implantation|Procedure: Simple colostomyhttps://ClinicalTrials.gov/show/NCT01380860
9054990549Prediction of Chronic Allograft NephropathyActive, not recruitingNo Results AvailableKidney Transplantation|Kidney Disease|Kidney Failure, ChronicGenetic: mRNAs encoding geneshttps://ClinicalTrials.gov/show/NCT01380847
9055090550Bilateral Paravertebral Blockade (T7-10) vs. Incisional Local Anesthetic Administration for Pediatric PatientsCompletedHas ResultsPain, PostoperativeDrug: control group|Drug: treatment grouphttps://ClinicalTrials.gov/show/NCT01380834
9055190551DNA Double-strand Breaks After SPECTCompletedNo Results AvailableCoronary Artery DiseaseRadiation: Myocardial SPECThttps://ClinicalTrials.gov/show/NCT01380821
9055290552Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)CompletedNo Results AvailableMetastatic Breast CancerDrug: capecitabine and pseudomonas aeruginosa combinationhttps://ClinicalTrials.gov/show/NCT01380808
9055390553Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial CarcinomasCompletedNo Results AvailableNon-small Cell Lung Cancer MetastaticBiological: CTChttps://ClinicalTrials.gov/show/NCT01380795
9055490554BIBF 1120 for Recurrent High-Grade GliomasCompletedHas ResultsGlioblastoma|Gliosarcoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic OligoastrocytomaDrug: BIBF 1120https://ClinicalTrials.gov/show/NCT01380782
9055590555A Phase 2 Study of CRLX101 in Patients With Advanced Non-Small Cell Lung CancerCompletedNo Results AvailableNon-Small Cell Lung CancerDrug: CRLX101|Other: Best Supportive Carehttps://ClinicalTrials.gov/show/NCT01380769
9055690556Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid LeukemiaCompletedNo Results AvailableCancer|Hematologic Malignancies|Leukemia|Myeloid LeukemiaDrug: Arm 1- Dose Escalation|Drug: Arm 2- Dose Expansionhttps://ClinicalTrials.gov/show/NCT01380756
9055790557Drug-drug Interaction StudyCompletedNo Results AvailablePompe DiseaseDrug: duvoglustat hydrochloridehttps://ClinicalTrials.gov/show/NCT01380743
9055890558LAPLACE-TIMI 57: LDL-C Assessment Wtih PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapyCompletedNo Results AvailableHyperlipidemiaBiological: evolocumab (AMG 145)|Biological: evolocumab (AMG 145)|Biological: evolocumab (AMG 145)|Biological: evolocumab (AMG 145)|Biological: evolocumab (AMG 145)|Biological: evolocumab (AMG 145)|Other: PLACEBO|Other: PLACEBOhttps://ClinicalTrials.gov/show/NCT01380730
9055990559Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD)CompletedNo Results AvailableChronic Kidney Insufficiency|Hypertension|VasodilationDrug: Beta-blocker, ACE-inhibitor|Drug: Calcium Channel Blockers, ACE-Inhibitorhttps://ClinicalTrials.gov/show/NCT01380717
9056090560Safety and Pharmacodynamic Study of ABT-436 in Major Depressive DisorderCompletedNo Results AvailableMajor Depressive DisorderDrug: ABT-436|Drug: Matching Placebohttps://ClinicalTrials.gov/show/NCT01380704
9056190561A Study of LY2216684 in Healthy SubjectsCompletedNo Results AvailableMajor Depressive DisorderDrug: LY2216684|Drug: LY2216684 Placebo|Drug: Alcohol Placebo containing beverage|Drug: Alcohol containing beveragehttps://ClinicalTrials.gov/show/NCT01380691
9056290562Intralesional Bevacizumab Injection on Primary PterygiumRecruitingNo Results AvailablePterygium|InflammationDrug: Intralesional injection of bevacizumab|Drug: Topical antihistamine and vasoconstrictorhttps://ClinicalTrials.gov/show/NCT01380678
9056390563Prevenaâ„¢ Incision Management System Over Primarily Closed Hip and Knee Incisions in Patients Immediately Post Total Hip and Knee ArthroplastyWithdrawnNo Results AvailableLinear or Emi-linear Incisions|Total Hip Arthroplasty|Total Knee ArthroplastyDevice: Prevena Incisional Management Systemhttps://ClinicalTrials.gov/show/NCT01380665
9056490564Vibration Training in Chronic Obstructive Pulmonary Disease (COPD)-Patients During a Three-week RehabilitationCompletedNo Results AvailableChronic Obstructive Pulmonary DiseaseProcedure: whole body vibration traininghttps://ClinicalTrials.gov/show/NCT01380652
9056590565Effects of Vibration Training on Exercise Capacity in COPD-patientsCompletedHas ResultsChronic Obstructive Pulmonary DiseaseOther: whole body vibration traininghttps://ClinicalTrials.gov/show/NCT01380639
9056690566Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patientsCompletedNo Results AvailableChronic Obstructive Pulmonary Disease|Alpha-1-antitrypsin-deficiencyProcedure: exercise traininghttps://ClinicalTrials.gov/show/NCT01380626
9056790567Neighborhoods, Networks, Depression, and HIV RiskCompletedNo Results AvailableHIV|Depression|Drug UseBehavioral: Workshop|Behavioral: Workshop controlhttps://ClinicalTrials.gov/show/NCT01380613
9056890568Safety Study of Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaActive, not recruitingNo Results AvailableCarcinoma, ColorectalDrug: Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594)https://ClinicalTrials.gov/show/NCT01380600
9056990569Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic LeukemiaCompletedNo Results AvailableAcute Lymphoblastic Leukemiahttps://ClinicalTrials.gov/show/NCT01380587
9057090570Safety of Cardioversion of Acute Atrial FibrillationCompletedNo Results AvailableAtrial Fibrillationhttps://ClinicalTrials.gov/show/NCT01380574

* Görseller ve İçerik tekif hakkına sahip olabilir